Aptevo Therapeutics Inc. — Director's Dealing 2019

Mar 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-02-28

Reporting Person: Mitchell Shawnte (SVP, GC and Corporate Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-01	Common Stock	M	6787	—	Acquired	82539	Direct
2019-03-01	Common Stock	F	2012	$1.57	Disposed	80527	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Stock Option (right to buy)	$1.52	A	67400	Acquired	2029-02-28	Common Stock (67400)	Direct
2019-03-01	Restricted Stock Unit	$	M	6787	Disposed		Common Stock (6787)	Direct

Footnotes

F1: Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis.

F2: The option vests in three approximately equal annual installments beginning on February 28, 2020.

F3: On March 1, 2016 the reporting person was granted 20,365 restricted stock units. 6,789 shares of common stock underlying the restricted stock units vested on each of March 1, 2017 and March 1, 2018, and the remaining 6,787 shares vested on March 1, 2019.